DNA methylation profiles in the hippocampus of an Alzheimer ’ s disease mouse model at midstage neurodegeneration

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Fucoxanthin, a Marine Carotenoid, Attenuates β-Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells

  2017cited by this paper
• Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs

  2017cited by this paper
• The Alzheimer’s disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons

  2017cited by this paper
• Elevated OPRD1 promoter methylation in Alzheimer’s disease patients

  2017cited by this paper
• Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment

  2016cited by this paper
• Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease.

  2015cited by this paper
• Reduced representation bisulfite sequencing design for assessing the methylation of human CpG islands in large samples

  2015cited by this paper
• Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease

  2015cited by this paper
• Effects of brain-derived neurotrophic factor-pretreated neuron stem cell transplantation on Alzheimer's disease model mice.

  2015cited by this paper
• Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease

  2015cited by this paper
• Roles for DSCAM and DSCAML1 in central nervous system development and disease.

  2014cited by this paper
• Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.

  2014influential reference
• Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism

  2014cited by this paper
• Erratum to: Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer’s disease

  2014influential reference
• The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?

  2014cited by this paper
• Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain

  2014cited by this paper
• ATP7B Variants as Modulators of Copper Dyshomeostasis in Alzheimer’s Disease

  2013cited by this paper
• SORL1 is Genetically Associated with Neuropathologically Characterized Late-Onset Alzheimer's Disease

  2013cited by this paper
• Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.

  2013influential reference
• Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients.

  2013cited by this paper
• Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression

  2012cited by this paper
• Planar cell polarity genes, Celsr1-3, in neural development

  2012cited by this paper
• Deletion of the amyloid precursor-like protein 2 (APLP2) does not affect hippocampal neuron morphology or function.

  2012cited by this paper
• Genome-Wide DNA Methylation Differences Between Late-Onset Alzheimer's Disease and Cognitively Normal Controls in Human Frontal Cortex

  2012influential reference
• Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.

  2012cited by this paper
• Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease.

  2012cited by this paper
• The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders

  2011cited by this paper
• Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line.

  2011cited by this paper
• Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant Mice

  2010cited by this paper
• Evidence supporting a role for the calcium‐sensing receptor in Alzheimer disease

  2009cited by this paper
• Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice

  2008cited by this paper
• Loss of presenilin function causes Alzheimer's disease‐like neurodegeneration in the mouse

  2008influential reference
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• Association Between Alzheimer’s Disease and the NOS3 gene Glu298Asp Polymorphism in Chinese

  2008cited by this paper
• The RELN Locus in Alzheimer's Disease

  2008cited by this paper
• Adult neurogenesis is functionally associated with AD-like neurodegeneration.

  2008influential reference
• RB1CC1 insufficiency causes neuronal atrophy through mTOR signaling alteration and involved in the pathology of Alzheimer's diseases.

  2007cited by this paper
• Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies.

  2006cited by this paper
• NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease

  2006cited by this paper
• Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis

  2005cited by this paper
• Expression of Catenin family members CTNNA1, CTNNA2, CTNNB1 and JUP in the primate prefrontal cortex and hippocampus.

  2005cited by this paper
• Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2.

  2004cited by this paper
• Absence of association between an intercellular adhesion molecule 1 gene E469K polymorphism and Alzheimer's disease in Finnish patients.

  2003cited by this paper

• The variation of 5 -carboxycytosine localization within the nucleus of normal and cancerous cells

  2022cites this paper
• The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases

  2022cites this paper